0Suppliers
3Customers
2Debt Items
0Related Chains

Immunocore Holdings plc Suppliers

No suppliers on recordImmunocore Holdings plc has not yet been matched to upstream suppliers in our database, or is still being processed.

Immunocore Holdings plc Customers

TickerNameConfidenceEvidence
GATES-FOUNDATION GATES-FOUNDATION 90% Under the terms of the Company's agreement with the Gates Foundation, the Company is required to develop, manufacture and commercialize soluble TCR bispecific therapeutic candidates targeted to mutua…
MEDISON MEDISON 85% Under the revised agreement, the Company received a non-refundable payment of $ 5.0 million in exchange for granting Medison exclusive distribution rights in South America.
MEDISON-PHARMA-LTD MEDISON-PHARMA-LTD 85% of net revenue from sale of therapies relating to the sale of KIMMTRAK primarily in the United States and Europe after estimated deductions for rebates, chargebacks and returns, which are recognized …

Immunocore Holdings plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
IMCR-DEBT Debt stack $435.7M 90% Market cache reports total debt of $435.7M.
IMCR-DEBT-10233 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-09-30.

Immunocore Holdings plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Immunocore Holdings plc.

Immunocore Holdings plc Ownership

HolderNameConfidenceEvidence
IMCR-OWNER-RTW-INVESTMENTS-LP RTW INVESTMENTS, LP 90% 13F overlay lists RTW INVESTMENTS, LP as top holder; 145 tracked holders.

Immunocore Holdings plc Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.